Cyprus Mail 28 March 2021 - by Reuters News Service
 |
| French Foreign Minister Yves le Drian warns UK against 'vaccine blackmail.' |
French Foreign Minister Jean-Yves Le Drian said on Friday Europe would not let itself be subjected to “a kind of blackmail” by Britain over supplies of Covid-19 vaccines.
European Union countries have said they are not receiving supplies of the shot promised by manufacturer AstraZeneca, among others, and have alleged Britain has been getting more than its fair share of the supplies.
Britain has said it does not believe in imposing vaccine blockades and that the EU must allow Covid-19 vaccine contracts to be fulfilled.
“We need to achieve a relationship of cooperation with the United Kingdom so AstraZeneca fulfils its commitments, signed with the European Union, and everyone gets what they need,” Le Drian told France Info television in an interview.
“But one cannot play like that, a kind of blackmail, where you wanted to vaccinate with all your might with the first dose and then you find yourself handicapped with the second doses. It’s not for Europe to bear the cost of this policy.”
Le Drian said Britain had outstripped Europe with its inoculation rates by focussing on first doses, while Europe was administering both first and second doses.
“I would just gently point out to anybody considering a blockade… that companies may look at such actions and draw conclusions about whether or not it is sensible to make future investments,” he said.
The EU this week tightened its oversight of coronavirus vaccine exports, giving it more scope to block shipments to countries with higher inoculation rates. British foreign minister Dominic Raab hit back, accusing the European Commission of brinkmanship.
France’s Health Minister Olivier Véran said 400,000 people had been vaccinated on Friday, which is just under the UK’s daily average. The country is hoping to step-up its vaccination programme in the coming weeks.
Also on Friday, Europe’s medicines regulator approved three factories for the production of coronavirus vaccines. A site in the Netherlands was cleared to produce the Oxford-AstraZeneca jab, while a German factory was given the go-ahead to make Pfizer/BioNTech doses.
A manufacturing site for the Moderna jab in Switzerland was also approved.
